Allergies
FDA Approves News Antihistmaine Xyzal
Filed in archive Allergy Medications , Hay Fever , Skin Allergies by ruth on September 4, 2007
FDA Approves News Antihistmaine Xyzal


There's a new non-sedating antihistamine coming into the US Market. The US FDA has approved levocetirizine dihydrochloride tablets (Xyzal, UCB and sanofi-aventis), a new rapid delivery once-daily prescription antihistamine for long-lasting symptomatic relief of seasonal and perennial allergies, as well as treatment of uncomplicated skin manifestations of chronic idiopathic urticaria (in simpler terms: chronic hives of unknown cause) in adults and children six years of age and older.

XYZAL® once-daily tablets are expected to be available during the 2007 fall allergy season. Read more detaiils about Xyzal-how it works, contraindications, side efects, etc- from the NetDoctor. See your allergist and find out is this is suitable for managing your allergies.

Permalink: FDA Approves News Antihistmaine Xyzal
Tags: xyzal  antihistamine  allergies  hives  urticaria  hay  fever  allergic  rhinitis  allergy  news+antihistmaine 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/89829
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for FDA Approves News Antihistmaine Xyzal:

  • Currently 6.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.67 out of 3 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!